Skip to main content

Resources

Explore our growing body of resources and research from across the women’s health innovation ecosystem.

Explore

    2024

    Academic Journal Article
    PCOS
    Communicable Diseases
    Asia-Pacific
    Europe
    Global
    Latin America & Caribbean
    Middle East
    North America

    A review on critical appraisal and pathogenesis of polycystic ovarian syndrome

    Hajam et al.

    Reviews data on the pathogenesis, diagnostic criteria, and multifactorial causes of polycystic ovarian syndrome to inform research and management strategies.

    Antiretrovirals in Pregnancy Research Toolkit

    2024

    Curricula and Trainings
    Resource Library
    Hepatitis (Viral)
    HIV
    Pregnancy & Fertility
    STIs
    Communicable Diseases
    Global

    Antiretrovirals in Pregnancy Research Toolkit

    World Health Organization

    Provides guidance and resources to support inclusion of pregnant and breastfeeding populations in HIV, hepatitis, and STI research, focusing on ethics, study design, and data collection.

    B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases

    2024

    Academic Journal Article
    Autoimmune diseases
    Communicable Diseases
    Global

    B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases

    Wang et al.

    Summarizes mechanisms and analytical methods for B-cell receptor repertoire diversity and reviews recent research on BCR repertoire in major autoimmune diseases.

    Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis Comparing a Short Course of Treatment With the Current South African Standard of Care.

    2024

    Database or Dataset
    Tuberculosis
    Communicable Diseases
    Africa

    Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis Comparing a Short Course of Treatment With the Current South African Standard of Care.

    ClinicalTrials.gov

    Provides information on a clinical trial to compare the efficacy and safety of a Study Strategy consisting of 6 months of bedaquiline (BDQ), delamanid (DLM), and linezolid (LNZ), with levofloxacin (LVX) and clofazimine (CFZ) compared to the current South African Standard of Care (Control Strategy) for 9 months for the treatment of rifampicin resistant (RR-TB) Tuberculosis.

    2024

    Academic Journal Article
    Communicable Diseases
    Africa
    Asia-Pacific
    Europe
    Global
    Latin America & Caribbean
    Middle East
    North America

    Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

    GBD 2021 Forecasting Collaborators

    Provides forecasts and scenario analyses of global disease burden, life expectancy, and risk factor impacts for 204 countries and territories to 2050 to support health policy planning.

    2004

    Academic Journal Article
    Communicable Diseases
    Ecosystem Progress
    Global

    Disparities in Infectious Diseases Among Women in Developing Countries

    Rashid, J. et al.

    Summarizes disparities in infectious disease burden among women in developing countries, highlighting contributing factors and barriers to healthcare access and treatment adherence.

    2024

    Academic Journal Article
    Autoimmune diseases
    Communicable Diseases
    Global

    DNA-sensing pathways in health, autoinflammatory and autoimmune diseases

    Dong & Fitzgerald

    Summarizes DNA-sensing pathways, their regulation, roles in host defense, and how their dysregulation contributes to autoinflammatory and autoimmune diseases, including therapeutic strategies.

    2024

    Academic Journal Article
    Antimicrobial Resistance (AMR)
    UTIs
    Communicable Diseases
    Asia-Pacific
    Europe
    Global
    North America

    Economic Burden Of Community-Acquired Antibiotic-resistant Urinary Tract Infections: Systematic Review And Meta-analysis

    Zhu et al.

    Synthesizes evidence on the economic, clinical, and health system burden of antibiotic-resistant community-acquired urinary tract infections to inform resource prioritization and intervention evaluation.

    2022

    Academic Journal Article
    Tuberculosis
    Communicable Diseases
    Africa

    Effect of Gender on Clinical Presentation Of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection

    Humayun, M. et al.

    Provides data on gender differences in TB incidence, clinical presentation, and TB-HIV coinfection in Harare, Zimbabwe, to inform targeted interventions.

    2024

    Academic Journal Article
    STIs
    Communicable Diseases
    Asia-Pacific
    Europe
    Global
    North America

    Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis

    Abara et al.

    Summarizes published data on MenB-4C vaccine effectiveness against gonorrhea, including pooled estimates, duration of protection, and implications for vaccine development.

    Emerging Infections and Pregnancy

    2006

    Academic Journal Article
    Pregnancy & Fertility
    Communicable Diseases
    Africa
    Asia-Pacific
    Europe
    Global
    Latin America & Caribbean
    North America

    Emerging Infections and Pregnancy

    Jamieson, D. J. et al.

    Summarizes how pregnancy alters immune response, increasing susceptibility and severity of emerging infectious diseases, to inform clinical and public health planning.

    2006

    Academic Journal Article
    Autoimmune diseases
    Cancer
    Cancer, Cervical
    Cancer, Colon
    Dementia
    Diabetes
    Lupus
    Neurological Disorders
    Tuberculosis
    Communicable Diseases
    Asia-Pacific
    Global
    North America

    Emerging Infectious Determinants of Chronic Diseases

    O’Connor, S. M. et al.

    Summarizes evidence linking infectious agents to chronic diseases, outlines mechanisms involved, and highlights implications for prevention and public health research.

Funding Opportunities

Curated global opportunities relevant to women’s health outcomes. 

This list is not meant to be comprehensive — reach out if you are aware of relevant opportunities we should add. Updated every two weeks.

Within 30 days Within 90 days 90+ days away Rolling / periodic
Funder Opportunity Type Focus Deadline
Loading opportunities...
Contact Us
Have a question, partnership idea, or specific request?

We’d love to hear from you.

Contact Us
Name